Exhaled carbon dioxide (CO 2 ) detection, in addition to lung inflation and increasing heart rate, is one of the most reliable methods of confirming accurate placement of an endotracheal tube during neonatal resuscitation, as reiterated in the 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 1 Both quantitative and qualitative methods of detection are available for use in the neonatal population. Qualitative devices rely on color change in a CO 2 -sensitive chemical and are a popular choice among neonatal care providers. 2 Historically, the first qualitative colorimetric devices used in neonates were designed for a population with body weight Ͼ15 kg and had a large internal volume (Ͼ20 mL). When incorporated into the respiratory circuit of neonates, such devices could add significant dead space and subsequent risk of rebreathing and hypercarbia, especially with prolonged use. 3 Current colorimetric devices approved for use in pediatric populations have overcome these issues by significantly reducing device internal volumes, allowing sensitive and timely detection of CO 2 at the low tidal volumes seen in the neonatal population. 4 The only colorimetric device labeled for use in the population with the smallest tidal volumes, the extremely low-birthweight infants with birthweight Ͻ1 kg, has an internal volume of 1 mL (Neo-StatCO 2 Ͻkg, Mercury Medical, Clearwater, Florida).
Accumulating evidence supporting the use of noninvasive respiratory support during delivery room resuscitation of premature infants has been recognized in the current American Heart Association guidelines. 1 As efforts to provide adequate resuscitation in premature neonates without intubations increase, the need for objective criteria to assess effectiveness of noninvasive resuscitation modes is also being increasingly investigated. [5] [6] [7] The feasibility and efficacy of exhaled CO 2 devices in establishing the adequacy of noninvasive ventilation either as face mask positive-pressure ventilation or in providing CPAP, both in clinical settings and in mannequin models, have been published. 5, 8, 9 Although not yet officially recommended due to lack of substantial outcome data, the ease and familiarity of using colorimetric devices make them excellent candidates for further research. 1, 7 As the field investigates SEE THE ORIGINAL STUDY ON PAGE 1003 potentially prolonged use of these devices with noninvasive support, the article by Brown et al 10 in this issue of RESPIRATORY CARE brings attention to a key characteristic of exhaled CO 2 devices, namely their air flow resistance. In an in vitro study, the investigators measured resistance as the pressure drop to atmosphere across the device for a given applied air flow. Three available pediatric colorimetric devices and 2 capnographs were investigated over increasing flow. To provide context for the results, they similarly measured the air-flow resistance of several sizes of neonatal endotracheal tubes.
Resistance in the product inserts of the devices investigated by Brown et al, 10 is depicted as back pressure generated by the device and is expressed in units of cm H 2 O for a particular flow. Calculating the resistance in units of cm H 2 O/L/s generates the values shown in Table 1 , which provides better visualized comparisons for the values generated by Brown et al. 10 We have added the specifications of the Stat-CO 2 (Mercury Medical, Clearwater, Florida), a device labeled for use in a population with body weight Ͼ15 kg, to provide context for the interplay between device internal volume and resistance. The resistance for each device was calculated by the investigators at increasing flow and clearly illustrates the rising resistance of devices with falling internal volume and rising flow ( that increased contact time was achieved by slowing the exhaled air, possibly contributing to the increased resistance, illustrated by the authors in Figure 4 10 in the multiple small holes through which the exhaled air is required to pass.
The consequences of such high resistance are appropriately noted by the authors. Some of these devices technically perform for up to 24 h, allowing the option for continued use, for example, during transport of intubated neonates. However, if unaccounted for, additional resistance has the potential to cause increased work of breathing and ultimately fatigue, de-recruitment, and atelectrauma. The authors provide context for the amount of resistance in the highest-resistance device by comparing it with a 3.0 endotracheal tube. In a way, this suggests that such resistance can be corrected for and managed within a ventilator system. However, if this device were to be applied to spontaneously breathing infants receiving CPAP or other forms of noninvasive ventilation, the additional resistance, if not anticipated, could result in deterioration of respiratory distress with prolonged use.
Although the study highlights an important variable that may not be routinely anticipated and accounted for in clinical practice, the study has some limitations. It is an in vitro study, and the investigators use a simplified method for measuring resistance. Previous exhaustive studies have demonstrated that air flow resistance through a conduit is highly influenced by dynamic effects on the air flow profile due to entrance and exit conditions (eg, sudden changes in tube diameter as well as by the turbulent vs laminar nature of the airstream 11, 12 ). Further, it has been shown that, under certain conditions, air flow resistance with oscillatory flows tends to be lower than resistance measured with a steady flow. 13 Use of a lung model utilizing commonly used airway tubing and adaptors and ventilated with a sinusoidal flow waveform to more realistically mimic in vivo conditions may have resulted in resistance measures more accurately approximating what an actual infant would experience. The authors recognize the need for clinical studies to measure the actual impact of such resistance. Until such studies are available, it seems prudent to avoid prolonged clinical use of neonatal colorimetric devices without accounting for the high reported in vitro resistance. 
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